Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)

被引：0
|
作者：
Saad, F.
Smith, M. R.
Egerdie, B.
Tammela, T. L.
Feldman, R. A.
Heracek, J.
Szwedowski, M.
Ke, C.
Leder, B.
Goessl, C.
机构：
[1] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada
[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[3] Urol Associates, Urol Med Res, Kitchener, ON, Canada
[4] Tampere Univ Hosp, Tampere, Finland
[5] Connecticut Clin Res Ctr, Urol Specialists, Middlebury, CT USA
[6] Androgeos, Prague, Czech Republic
[7] Wojewodzkie Ctr Medyczne, Opole, Poland
[8] Amgen Inc, Thousand Oaks, CA 91320 USA
[9] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5056
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Egerdie, Blair
    Toriz, Narciso Hernandez
    Feldman, Robert
    Tammela, Teuvo L. J.
    Saad, Fred
    Heracek, Jiri
    Szwedowski, Maciej
    Ke, Chunlei
    Kupic, Amy
    Leder, Benjamin Z.
    Goessl, Carsten
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 745 - 755
  • [2] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 1012 - 1013
  • [3] ORGASM IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Mazzola, C.
    Teloken, P. E.
    Matsuhsita, K.
    Nelson, C. J.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S50 - S50
  • [4] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Egerdie, Blair
    Szwedowski, Maciej
    Tammela, Teuvo L. J.
    Ke, Chunlei
    Leder, Benjamin Z.
    Goessl, Carsten
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2670 - 2675
  • [5] ORGASM PROFILES IN MEN ON ANDROGEN DEPRIVATION THERAPY (ADT) FOR PROSTATE CANCER
    Teloken, Patrick
    Mazzola, Clarisse R.
    Mulhall, John P.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E572 - E572
  • [6] Recommendations for use of zoledronic acid (Z) for prevention and treatment of osteoporosis in men on androgen deprivation therapy (ADT) for prostate cancer (PC)
    Pandya, M. B.
    Broderick, W.
    Campbell, S. C.
    Garewal, H.
    Friedman, N.
    Moritz, T.
    Reda, D.
    Bhoopalam, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Factors associated with vertebral fractures in men treated with androgen-deprivation therapy (ADT) for prostate cancer
    Saylor, P. J.
    Hancock, M. L.
    Barnette, G.
    Steiner, M. S.
    Morton, R. A.
    Smith, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [8] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer COMMENT
    Singer, Frederick R.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2676 - 2676
  • [9] Androgen deprivation therapy (ADT) and physical function in men with nonmetastatic prostate cancer
    Breunis, H.
    Leach, M.
    Naglie, G.
    Tannock, I. F.
    Fleshner, N. E.
    Krahn, M.
    Duff-Canning, S.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT).
    Hanlon, Ashley
    Fleming, Steven
    Hamilton, Ann S.
    Dinan, Michaela Ann
    Melloni, Chiara
    Harrison, Michael Roger
    Khouri, Michel
    Wu, Xiao-cheng
    Wilson, J. Frank
    Lipscomb, Joseph
    Cress, Rosemary Donaldson
    Anderson, Roger T.
    Kimmick, Gretchen Genevieve
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07)
12345